The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F. Kennedy Jr. replaced its roster.

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are at risk of severe disease.

(NewsNation) — Health and Human Services Secretary Robert F. Kennedy Jr.’s vaccine committee on Thursday voted to recommend a shot that protects babies against RSV, reports said. The shot ...

The health and human services secretary has repeatedly claimed children need dozens more vaccines than they actually do.

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

In case you missed: RFK Jr. fires entire CDC vaccine advisory panel The Beyfortus shot was recommended by ACIP in 2023 for babies under 9 months old who are entering their first RSV season.

The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the same family as the Ebola virus ...

CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.